132 related articles for article (PubMed ID: 10816061)
1. Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarction.
Gurbel PA; Kereiakes DJ; Atar D; Serebruany VL
Scand Cardiovasc J; 2000; 34(1):53-8. PubMed ID: 10816061
[TBL] [Abstract][Full Text] [Related]
2. Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators.
Serebruany VL; Gurbel PA; Shustov AR; Dalesandro MR; Gumbs CI; Grabletz LB; Bahr RD; Ohman EM; Topol EJ
Stroke; 1998 Jan; 29(1):235-8. PubMed ID: 9445356
[TBL] [Abstract][Full Text] [Related]
3. Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting with acute myocardial infarction. The GUSTO-III Platelet Substudy.
Serebruany VL; Bahr RD; O'Connor CM; Lowry DR; Gurbel PA
Cardiology; 1998 Jul; 90(1):37-42. PubMed ID: 9693169
[TBL] [Abstract][Full Text] [Related]
4. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.
Gurbel PA; Serebruany VL; Shustov AR; Bahr RD; Carpo C; Ohman EM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1466-73. PubMed ID: 9626821
[TBL] [Abstract][Full Text] [Related]
5. Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis.
Gurbel PA; Serebruany VL; Shustov AR; Dalesandro M; Gumbs CI; Grablutz LB; Bahr RD; Ohman EM; Topol EJ
Coron Artery Dis; 1998; 9(7):451-6. PubMed ID: 9822864
[TBL] [Abstract][Full Text] [Related]
6. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease.
Malinin AI; Atar D; Callahan KP; McKenzie ME; Serebruany VL
Eur J Pharmacol; 2003 Feb; 462(1-3):139-43. PubMed ID: 12591106
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction.
Serebruany VL; Gurbel PA; Shustov AR; Ohman EM; Topol EJ
Am Heart J; 1998 Sep; 136(3):398-405. PubMed ID: 9736129
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.
Peter K; Kohler B; Straub A; Ruef J; Moser M; Nordt T; Olschewski M; Ohman ME; Kübler W; Bode C
Circulation; 2000 Sep; 102(13):1490-6. PubMed ID: 11004138
[TBL] [Abstract][Full Text] [Related]
9. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
10. Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy.
Serebruany VL; Malinin AI; Callahan KP; Binbrek A; Van De Werf F; Alexander JH; Granger CB; Gurbel PA;
Am Heart J; 2003 Apr; 145(4):636-42. PubMed ID: 12679759
[TBL] [Abstract][Full Text] [Related]
11. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.
Coulter SA; Cannon CP; Ault KA; Antman EM; Van de Werf F; Adgey AA; Gibson CM; Giugliano RP; Mascelli MA; Scherer J; Barnathan ES; Braunwald E; Kleiman NS
Circulation; 2000 Jun; 101(23):2690-5. PubMed ID: 10851205
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.
Kleiman NS; Tracy RP; Talley JD; Sigmon K; Joseph D; Topol EJ; Califf RM; Kitt M; Ohman EM
J Thromb Thrombolysis; 2000 Jan; 9(1):5-12. PubMed ID: 10590183
[TBL] [Abstract][Full Text] [Related]
13. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
Xiao Z; Théroux P; Frojmovic M
Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
[TBL] [Abstract][Full Text] [Related]
14. Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.
Moser M; Nordt T; Peter K; Ruef J; Kohler B; Schmittner M; Smalling R; Kübler W; Bode C
Circulation; 1999 Nov; 100(18):1858-64. PubMed ID: 10545429
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction.
Ault KA; Cannon CP; Mitchell J; McCahan J; Tracy RP; Novotny WF; Reimann JD; Braunwald E
J Am Coll Cardiol; 1999 Mar; 33(3):634-9. PubMed ID: 10080462
[TBL] [Abstract][Full Text] [Related]
16. Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction.
Serebruany VL; Gurbel PA
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):153-8. PubMed ID: 9888878
[TBL] [Abstract][Full Text] [Related]
17. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
18. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis.
Eccleston D; Topol EJ
Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017
[No Abstract] [Full Text] [Related]
20. Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction.
Szabo S; Etzel D; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
J Thromb Thrombolysis; 2005 Dec; 20(3):155-61. PubMed ID: 16261288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
